United States Parkinson's Disease Drug Market Report 2018

Table of Contents

United States Parkinson's Disease Drug Market Report 2017
1 Parkinson's Disease Drug Overview
1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Classification of Parkinson's Disease Drug by Product Category
1.2.1 United States Parkinson's Disease Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Parkinson's Disease Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Sinemet-CR
1.2.4 Trastal
1.2.5 Madopar
1.2.6 COMT Inhibitor
1.2.7 Other
1.3 United States Parkinson's Disease Drug Market by Application/End Users
1.3.1 United States Parkinson's Disease Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 United States Parkinson's Disease Drug Market by Region
1.4.1 United States Parkinson's Disease Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.3 Southwest Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.5 New England Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.6 The South Parkinson's Disease Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Parkinson's Disease Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Parkinson's Disease Drug (2012-2022)
1.5.1 United States Parkinson's Disease Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Parkinson's Disease Drug Revenue and Growth Rate (2012-2022)

2 United States Parkinson's Disease Drug Market Competition by Players/Suppliers
2.1 United States Parkinson's Disease Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Parkinson's Disease Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Parkinson's Disease Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Parkinson's Disease Drug Market Competitive Situation and Trends
2.4.1 United States Parkinson's Disease Drug Market Concentration Rate
2.4.2 United States Parkinson's Disease Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Parkinson's Disease Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Parkinson's Disease Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Parkinson's Disease Drug Sales and Market Share by Region (2012-2017)
3.2 United States Parkinson's Disease Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Parkinson's Disease Drug Price by Region (2012-2017)

4 United States Parkinson's Disease Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Parkinson's Disease Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Parkinson's Disease Drug Price by Type (2012-2017)
4.4 United States Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)

5 United States Parkinson's Disease Drug Sales (Volume) by Application (2012-2017)
5.1 United States Parkinson's Disease Drug Sales and Market Share by Application (2012-2017)
5.2 United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Parkinson's Disease Drug Players/Suppliers Profiles and Sales Data
6.1 Merck
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Parkinson's Disease Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Merck Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Akorn
6.2.2 Parkinson's Disease Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Akorn Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.2 Parkinson's Disease Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Parkinson's Disease Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Boehringer Ingelheim
6.5.2 Parkinson's Disease Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical
6.6.2 Parkinson's Disease Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Abbvie
6.7.2 Parkinson's Disease Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Abbvie Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Kyowa Hakko Kirin Pharma
6.8.2 Parkinson's Disease Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Astellas Pharma
6.9.2 Parkinson's Disease Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Desitin Arzneimittel
6.10.2 Parkinson's Disease Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Endo Pharmaceuticals
6.12 F.Hoffmann-La Roche
6.13 H.Lundbeck
6.14 Valeant
6.15 Apokyn
6.16 Orion
6.17 Stada Arzneimittel
6.18 US WorldMeds
6.19 Valeant Pharmaceuticals

7 Parkinson's Disease Drug Manufacturing Cost Analysis
7.1 Parkinson's Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Parkinson's Disease Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Parkinson's Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Parkinson's Disease Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Parkinson's Disease Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Parkinson's Disease Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Parkinson's Disease Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Parkinson's Disease Drug Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Parkinson's Disease Drug
Figure United States Parkinson's Disease Drug Market Size (K Units) by Type (2012-2022)
Figure United States Parkinson's Disease Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Sinemet-CR Product Picture
Figure Trastal Product Picture
Figure Madopar Product Picture
Figure COMT Inhibitor Product Picture
Figure Other Product Picture
Figure United States Parkinson's Disease Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Parkinson's Disease Drug by Application in 2016
Figure Under 40 Years Old Examples
Table Key Downstream Customer in Under 40 Years Old
Figure 40-65 Years Old Examples
Table Key Downstream Customer in 40-65 Years Old
Figure Above 65 Years Old Examples
Table Key Downstream Customer in Above 65 Years Old
Figure United States Parkinson's Disease Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Parkinson's Disease Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure United States Parkinson's Disease Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Parkinson's Disease Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Parkinson's Disease Drug Revenue Share by Players/Suppliers
Figure 2017 United States Parkinson's Disease Drug Revenue Share by Players/Suppliers
Table United States Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Parkinson's Disease Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Parkinson's Disease Drug Market Share of Top 3 Players/Suppliers
Figure United States Parkinson's Disease Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Parkinson's Disease Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Parkinson's Disease Drug Product Category
Table United States Parkinson's Disease Drug Sales (K Units) by Region (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Sales Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Region in 2016
Table United States Parkinson's Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Revenue Market Share by Region (2012-2017)
Figure United States Parkinson's Disease Drug Revenue Market Share by Region in 2016
Table United States Parkinson's Disease Drug Price (USD/Unit) by Region (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Type in 2016
Table United States Parkinson's Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type in 2016
Table United States Parkinson's Disease Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales (K Units) by Application (2012-2017)
Table United States Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Application in 2016
Table United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Merck Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Merck Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Akorn Basic Information List
Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Akorn Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure GSK Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure GSK Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Novartis Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Abbvie Basic Information List
Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Kyowa Hakko Kirin Pharma Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Desitin Arzneimittel Basic Information List
Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Growth Rate (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Market Share in United States (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share in United States (2012-2017)
Table Endo Pharmaceuticals Basic Information List
Table F.Hoffmann-La Roche Basic Information List
Table H.Lundbeck Basic Information List
Table Valeant Basic Information List
Table Apokyn Basic Information List
Table Orion Basic Information List
Table Stada Arzneimittel Basic Information List
Table US WorldMeds Basic Information List
Table Valeant Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Players/Suppliers in 2016
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure United States Parkinson's Disease Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Parkinson's Disease Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Parkinson's Disease Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Parkinson's Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Parkinson's Disease Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.